DESTINY-Lung02 phase 2 trial shows clinically meaningful efficacy and favorable safety at 5.4 mg/kg dose…
Extended follow-up data from phase 1/2 trial of DS-7300 in patients with metastatic lung, prostate…
Tislelizumab demonstrated non-inferiority for overall survival and favorable safety profile versus sorafenib in global Phase…
HONG KONG--(BUSINESS WIRE)--#insurance--AM Best has revised the implications of the under review status to positive…
DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Archiving Ediscovery Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.…
DUBLIN--(BUSINESS WIRE)--The "Interior Decorative Products Markets in China" report has been added to ResearchAndMarkets.com's offering.…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Healthcare Fraud Analytics Market Size, Share & Industry Trends Analysis Report…
DUBLIN--(BUSINESS WIRE)--The "Leadership Quadrant of Bio-Plasticizer Suppliers - 2022" report has been added to ResearchAndMarkets.com's…
DUBLIN--(BUSINESS WIRE)--The "Digital Rights Management Market - Vietnam Industry Size, Share, Trends, Opportunity, and Forecast,…
SEOUL, South Korea--(BUSINESS WIRE)--#AIDataService--INFINIQ, the leading AI data company in South Korea, has introduced a…